Pdt Partners, LLC Viatris Inc Transaction History

Pdt Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $1.04 Million - $1.38 Million	-118,979 Reduced 83.88%	22,873 $254,000
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $993,092 - $1.3 Million	-117,110 Reduced 45.22%	141,852 $1.21 Million
Q2 2022 Aug 15, 2022	BUY	$9.95 - $12.27 $1.83 Million - $2.26 Million	184,305 Added 246.87%	258,962 $2.71 Million
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $732,385 - $1.15 Million	74,657 New	74,657 $812,000

1,135

987M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.6B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.